A national propensity score-matched analysis of simultaneous pancreas and kidney transplantation from donation after circulatory death and brain death donors
Abstract
Increased use of donation after circulatory death (DCD) organs can lessen the ongoing organ shortage in transplantation. While DCD donor utilization has increased in other types of organ transplantation, with outcomes comparable to donation after brain death (DBD) donors, DCD use in pancreas transplantation is declining. To rigorously define the risk of DCD pancreas donors and control for confounding variables, we performed a propensity score-matched analysis of adult simultaneous pancreas-kidney (SPK) transplantations. Using data from the Organ Procurement and Transplantation Network (OPTN) registry, we examined 1036 propensity-matched pancreas transplant recipients of 777 DBD and 259 DCD donor organs between 2010 and 2022. In univariable Cox proportional hazards models fitted in the propensity score-matched cohort, with robust variance estimates clustered by matched set, SPK recipients of DCD donors had post-transplant patient and graft survival outcomes comparable to those of DBD donors at 1 and 3 years. DCD recipients experienced similar rates of treatment for graft rejection at 6 months and 1 year, comparable rates of postoperative complications, and similar renal function at 1 year compared with DBD recipients. SPK recipients of DCD donors benefited from significantly shorter wait times for organs than recipients of DBD donors. The use of DCD donors in pancreas transplantation can safely increase organ availability.
Related
- Speckle Tracking Analysis of the Left and Right Heart in Type 1 Diabetes Patients with End-Stage Renal Disease Awaiting Simultaneous Pancreas-Kidney Transplantation.
- Pediatric Kidney Alone Versus Adult Simultaneous Kidney–Pancreas Recipients of Deceased Donor Kidneys: A Paired Analysis of 1675 Donors
- Modeling the cost-effectiveness of introducing donation after controlled circulatory death for heart transplantation in France
- Belatacept Conversion in Simultaneous Pancreas-Kidney and Liver-Kidney Transplant Recipients: A Single-Center Feasibility Cohort and Narrative Review.
- Impact of Donor Substance Use on Outcomes Following Pancreas Transplantation.
BibTeX
@article{lim2026national,
title = {{A national propensity score-matched analysis of simultaneous pancreas and kidney transplantation from donation after circulatory death and brain death donors}},
author = {Tiffany Y Lim and Emma Crichton and Evronia Baselious and Tia Ketsan and Alexander Jurkovich and Yujie Cui and Nicholas N. Nissen and Kambiz Kosari and Georgios Voidonikolas and Tsuyoshi Todo and Justin A. Steggerda and Steven A. Wisel and Irene K. Kim and Todd V. Brennan},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-74180-5},
url = {https://www.nature.com/articles/s41598-026-74180-5},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A national propensity score-matched analysis of simultaneous pancreas and kidney transplantation from donation after circulatory death and brain death donors
AU - Tiffany Y Lim
AU - Emma Crichton
AU - Evronia Baselious
AU - Tia Ketsan
AU - Alexander Jurkovich
AU - Yujie Cui
AU - Nicholas N. Nissen
AU - Kambiz Kosari
AU - Georgios Voidonikolas
AU - Tsuyoshi Todo
AU - Justin A. Steggerda
AU - Steven A. Wisel
AU - Irene K. Kim
AU - Todd V. Brennan
PY - 2026
DA - 2026/10/01
JO - Scientific Reports
DO - 10.1038/s41598-026-74180-5
UR - https://www.nature.com/articles/s41598-026-74180-5
AB - Increased use of donation after circulatory death (DCD) organs can lessen the ongoing organ shortage in transplantation. While DCD donor utilization has increased in other types of organ transplantation, with outcomes comparable to donation after brain death (DBD) donors, DCD use in pancreas transplantation is declining. To rigorously define the risk of DCD pancreas donors and control for confounding variables, we performed a propensity score-matched analysis of adult simultaneous pancreas-kidney (SPK) transplantations. Using data from the Organ Procurement and Transplantation Network (OPTN) registry, we examined 1036 propensity-matched pancreas transplant recipients of 777 DBD and 259 DCD donor organs between 2010 and 2022. In univariable Cox proportional hazards models fitted in the propensity score-matched cohort, with robust variance estimates clustered by matched set, SPK recipients of DCD donors had post-transplant patient and graft survival outcomes comparable to those of DBD donors at 1 and 3 years. DCD recipients experienced similar rates of treatment for graft rejection at 6 months and 1 year, comparable rates of postoperative complications, and similar renal function at 1 year compared with DBD recipients. SPK recipients of DCD donors benefited from significantly shorter wait times for organs than recipients of DBD donors. The use of DCD donors in pancreas transplantation can safely increase organ availability.
SN - 2045-2322
ER -